Treats infections caused by susceptible strains of the designated organisms in the…. ANDA 62055, held by Ani Pharms. Erythromycin Ethylsuccinate.
As of Nov 16, 2026, ANDA 62055 (Erythromycin Ethylsuccinate), held by Ani Pharms, was first approved by FDA on Nov 27, 1978, with 19 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin ethylsuccinate and other antibacterial drugs, erythromycin ethylsuccinate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 27, 1978 | Original application | Approved | None posted |
| Erythromycin EthylsuccinateEQ 200MG BASE/5ML · granule;oral | Erythromycin Ethylsuccinate | Rx |
| Erythromycin EthylsuccinateEQ 400MG BASE/5ML · granule;oral | Erythromycin Ethylsuccinate | Rx |
| Erythromycin EthylsuccinateEQ 200MG BASE/5ML · granule;oral | Erythromycin Ethylsuccinate | Rx |
| Nov 2, 2018 | Supplement 35Manufacturing | Approved | |
| Nov 2, 2018 | Supplement 34Manufacturing | Approved | |
| Apr 25, 2014 | Supplement 32Labeling · Standard review | Approved | None posted |
| Jun 1, 2001 | Supplement 31Labeling | Approved | None posted |
| May 24, 2001 | Supplement 30Manufacturing | Approved | None posted |
| Feb 14, 2001 | Supplement 29Labeling | Approved | None posted |
| Dec 21, 1999 | Supplement 28Manufacturing | Approved | None posted |
| May 20, 1999 | Supplement 27Manufacturing | Approved | None posted |
| Dec 1, 1998 | Supplement 25Manufacturing | Approved | None posted |
| Oct 8, 1998 | Supplement 26Labeling | Approved | None posted |
| Sep 25, 1998 | Supplement 24Manufacturing | Approved | None posted |
| Sep 22, 1995 | Supplement 23Manufacturing | Approved | None posted |
| Dec 23, 1994 | Supplement 22Manufacturing | Approved | None posted |
| Oct 11, 1994 | Supplement 21Manufacturing | Approved | None posted |
| Jul 1, 1993 | Supplement 20Labeling | Approved | None posted |
| Apr 29, 1992 | Supplement 15Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 19Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 17Manufacturing | Approved | None posted |
| Feb 25, 1992 | Supplement 16Labeling | Approved | None posted |
| Nov 27, 1978 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters